NBY (NovaBay Pharmaceuticals, Inc.) Stock Analysis - Insider Trades

NovaBay Pharmaceuticals, Inc. (NBY) is a publicly traded Healthcare sector company. As of May 21, 2026, NBY trades at $1.95 with a market cap of $51.92M and a P/E ratio of 0.12. NBY moved +23.42% today. Year to date, NBY is -62.14%; over the trailing twelve months it is -31.82%. Its 52-week range spans $1.11 to $99.75. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces NBY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading NBY stock inside the company?

Recent NBY insider activity includes POPLAR POINT CAPITAL PARTNERS LP bought 300, POPLAR POINT CAPITAL PARTNERS LP bought 4.54K, POPLAR POINT CAPITAL PARTNERS LP bought 22.98K, POPLAR POINT CAPITAL PARTNERS LP bought 917, and POPLAR POINT CAPITAL PARTNERS LP bought 19.91K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

NBY Key Metrics

Key financial metrics for NBY
MetricValue
Price$1.95
Market Cap$51.92M
P/E Ratio0.12
EPS$16.10
Dividend Yield0.80%
52-Week High$99.75
52-Week Low$1.11
Volume637.60K
Avg Volume0
Revenue (TTM)$2.46M
Net Income$522.59M
Gross Margin0.00%

Recent NBY Insider Trades

  • POPLAR POINT CAPITAL PARTNERS LP bought 300 (~$139.5) on Apr 8, 2025.
  • POPLAR POINT CAPITAL PARTNERS LP bought 4.54K (~$2.37K) on Apr 4, 2025.
  • POPLAR POINT CAPITAL PARTNERS LP bought 22.98K (~$12.93K) on Apr 3, 2025.
  • POPLAR POINT CAPITAL PARTNERS LP bought 917 (~$531.86) on Apr 2, 2025.
  • POPLAR POINT CAPITAL PARTNERS LP bought 19.91K (~$11.65K) on Apr 1, 2025.

Latest NBY News

NBY Analyst Consensus

5 analysts cover NBY: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.

Common questions about NBY

Who is trading NBY stock inside the company?
Recent NBY insider activity includes POPLAR POINT CAPITAL PARTNERS LP bought 300, POPLAR POINT CAPITAL PARTNERS LP bought 4.54K, POPLAR POINT CAPITAL PARTNERS LP bought 22.98K, POPLAR POINT CAPITAL PARTNERS LP bought 917, and POPLAR POINT CAPITAL PARTNERS LP bought 19.91K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for NBY?
Yes. Rallies tracks NBY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is NBY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NBY. It does not provide personalized investment advice.
NBY

NBY